Soley Therapeutics (Series C)
Funding Details
Awarder
Inbox
Date Award
January 12, 2026
Vertical
Biotechnology
Funding Amount
$200,000,000
Company Info
Founders
Yerem Yeghiazarians
Market
Pharmaceuticals
Location
South San Francisco, California, USA
Coinvestors
Breyer Capital, Doug Leone Family Fund, GordonMD Global Investments, HRTG Partners, RWN Management, Surveyor Capital
Company Description

Soley Therapeutics is a science-first, tech-enabled drug discovery and development company using cells as the world's most powerful sensors to uncover first-in-class medicines. Soley's platform translates the cellular information of stress biology into mechanistic insight, revealing novel drug candidates that otherwise would be missed. Soley deploys full-stack AI via its collaboration with Oracle, including OCI AI Infrastructure, NVIDIA AI Enterprise and NVIDIA Blackwell GPUs.

Links